Using mobile technology to manage cardiovascular risks in stroke patients
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
This study is testing if using mobile technology to monitor blood pressure and check for heart rhythm problems can help stroke patients manage their cardiovascular risks better than standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 405 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Hospital District of Helsinki and Uusimaa Academic / other |
| Locations | 4 sites (Hämeenlinna and 3 other locations) |
| Trial ID | NCT03710902 on ClinicalTrials.gov |
What this trial studies
The CARDIOSTROKE trial is a randomized study that compares mobile-device-assisted management of hypertension and screening for hidden atrial fibrillation against standard care in patients who have recently experienced an ischemic stroke or transient ischemic attack. The trial aims to enroll 405 participants, who will be divided into two groups: one receiving standard care and the other undergoing three weeks of ECG monitoring and self-monitoring of blood pressure with the help of mobile technology. The primary outcomes include the detection of new-onset atrial fibrillation and changes in mean blood pressure after 12 months. This innovative approach seeks to improve the management of cardiovascular risk factors in stroke patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 40 and older who have experienced an ischemic stroke or transient ischemic attack and have hypertension.
Not a fit: Patients with known high-risk sources of cardioembolism or those who are already indicated for anticoagulation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better control of hypertension and early detection of atrial fibrillation, significantly reducing the risk of recurrent strokes.
How similar studies have performed: Other studies have shown promise in using mobile technology for managing cardiovascular risks, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ischemic stroke or transient ischemic attack (ABCD2 score ≥3) * Age ≥40 years * Pre-existing or newly diagnosed hypertension * Informed consent from the patient or legal representative Exclusion Criteria: * Known high-risk source of cardioembolism * Known indication for anticoagulation * Contraindication for anticoagulation * Pacemaker * Non-compliance to study interventions as judged by the investigator * Serious condition hampering the study conduct
Where this trial is running
Hämeenlinna and 3 other locations
- Kanta-Häme Central Hospital — Hämeenlinna, Finland (Recruiting)
- Helsinki University Hospital — Helsinki, Finland (Recruiting)
- Hyvinkää Hospital — Hyvinkää, Finland (Recruiting)
- Päijät-Häme Central Hospital — Lahti, Finland (Recruiting)
Study contacts
- Study coordinator: Tuomas Lumikari, MD
- Email: tuomas.lumikari@helsinki.fi
- Phone: +35894711
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.